• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Atopic Dermatitis

The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

Latest News

FDA stamp of approval | Image Credit: Olivier Le Moal - stock.adobe.com
FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis

December 16th 2024

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis.

man resting hands on top of walking cane | Image Credit: sergign - stock.adobe.com
Study Finds Increased Impaired Mobility by Sex, Age in Atopic Dermatitis

June 30th 2024

E-cigarettes | Image Credit: lezinav - stock.adobe.com
Parental e-Cigarette Use May Increase Pediatric AD Risk

May 22nd 2024

Female patient with AD | Image Credit: Prostock-studio - stock.adobe.com
Study: Visible AD Impacts Romantic Relationships, Occupation, Sexual Health of French Female Patients

May 19th 2024

Patient scratching atopic dermatitis (AD) on hand | Image Credit: Ольга Тернавская - stock.adobe.com
Patients With AD Prioritize Itch Control in Treatment Preferences

May 14th 2024

<1
...
45678
© 2025 MJH Life Sciences
AJMC®
All rights reserved.